chlorpheniramine maleate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenyltoloxamine citrate 1.5 MG/ML Oral Solution

RxCUI
1308442
RxNorm name
chlorpheniramine maleate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenyltoloxamine citrate 1.5 MG/ML Oral Solution
Term type
SCD
Status
Active
Updated
2026-08-01 06:54:53

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102012
Active start
102012
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
chlorpheniramine maleate0.5 MG / 1 MLchlorpheniraminechlorpheniramine maleate
phenyltoloxamine citrate1.5 MG / 1 MLphenyltoloxaminephenyltoloxamine citrate
phenylephrine hydrochloride1 MG / 1 MLphenylephrinephenylephrine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Solution316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
chlorpheniramine2400
phenyltoloxamine33408
phenylephrine8163

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 10 matching rows.

NDC11, Source, Active table
NDC11SourceActive
51301014015rxnav_historical_indirect
51301014016rxnav_historical_indirect
51674000705rxnav_historical_indirect
51674000707rxnav_historical_indirect
51991013716rxnav_historical_indirect
59741016016rxnav_historical_indirect
62542052016rxnav_historical_indirect
62542056016rxnav_historical_indirect
64376043116rxnav_historical
68047016216rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC01CAAdrenergic and dopaminergic agentsATC1-4phenylephrine
ATCC05AXOther agents for treatment of hemorrhoids and anal fissures for topical useATC1-4phenylephrine
ATCR06ABSubstituted alkylaminesATC1-4chlorpheniramine
ATCR01BASympathomimeticsATC1-4phenylephrine
ATCS01FBSympathomimetics excl. antiglaucoma preparationsATC1-4phenylephrine
ATCS01GASympathomimetics used as decongestantsATC1-4phenylephrine
ATCR01ABSympathomimetics, combinations excl. corticosteroidsATC1-4phenylephrine
ATCR01AASympathomimetics, plainATC1-4phenylephrine
FDASPLN0000186105alpha-1 Adrenergic AgonistEPChas_epcphenylephrine
FDASPLN0000175587Histamine-1 Receptor AntagonistEPChas_epcchlorpheniramine
MEDRTD001559Benzhydryl CompoundsCHEMhas_ingredientphenyltoloxamine
MEDRTD002744ChlorpheniramineCHEMhas_ingredientchlorpheniramine
MEDRTD002744ChlorpheniramineCHEMhas_ingredientchlorpheniramine maleate
MEDRTD010656PhenylephrineCHEMhas_ingredientphenylephrine hydrochloride
MEDRTD010656PhenylephrineCHEMhas_ingredientphenylephrine
MEDRTD013447SulfitesCHEMci_chemclassphenylephrine
MEDRTD013447SulfitesCHEMci_chemclassphenylephrine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withphenyltoloxamine citrate
MEDRTD004342Drug HypersensitivityDISEASEci_withphenylephrine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withchlorpheniramine maleate
MEDRTD004342Drug HypersensitivityDISEASEci_withphenylephrine
MEDRTD004342Drug HypersensitivityDISEASEci_withphenyltoloxamine
MEDRTD004342Drug HypersensitivityDISEASEci_withchlorpheniramine
MEDRTD004380Duodenal ObstructionDISEASEci_withchlorpheniramine maleate
MEDRTD004380Duodenal ObstructionDISEASEci_withchlorpheniramine
MEDRTD005401Fissure in AnoDISEASEmay_treatphenylephrine hydrochloride
MEDRTD005401Fissure in AnoDISEASEmay_treatphenylephrine
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withchlorpheniramine
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withchlorpheniramine maleate
MEDRTD005902Glaucoma, Open-AngleDISEASEmay_treatphenylephrine
MEDRTD005902Glaucoma, Open-AngleDISEASEmay_treatphenylephrine hydrochloride
MEDRTD006484HemorrhoidsDISEASEmay_treatphenylephrine
MEDRTD006484HemorrhoidsDISEASEmay_treatphenylephrine hydrochloride
MEDRTD006973HypertensionDISEASEci_withphenylephrine
MEDRTD006973HypertensionDISEASEci_withphenylephrine hydrochloride
MEDRTD007022HypotensionDISEASEmay_treatphenylephrine
MEDRTD007022HypotensionDISEASEmay_treatphenylephrine hydrochloride
MEDRTD007231Infant, NewbornDISEASEci_withchlorpheniramine
MEDRTD007231Infant, NewbornDISEASEci_withchlorpheniramine maleate
MEDRTD007234Infant, PrematureDISEASEci_withchlorpheniramine
MEDRTD007234Infant, PrematureDISEASEci_withchlorpheniramine maleate
MEDRTD015878MydriasisDISEASEinducesphenylephrine
MEDRTD015878MydriasisDISEASEinducesphenylephrine hydrochloride
MEDRTD010437Peptic UlcerDISEASEci_withchlorpheniramine
MEDRTD010437Peptic UlcerDISEASEci_withchlorpheniramine maleate
MEDRTD011470Prostatic HyperplasiaDISEASEci_withchlorpheniramine maleate
MEDRTD011470Prostatic HyperplasiaDISEASEci_withchlorpheniramine
MEDRTD011538Pruritus AniDISEASEmay_treatphenylephrine hydrochloride
MEDRTD011538Pruritus AniDISEASEmay_treatphenylephrine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatphenyltoloxamine citrate
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatphenyltoloxamine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatchlorpheniramine maleate
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatchlorpheniramine
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatphenylephrine
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatphenylephrine hydrochloride
MEDRTD012772Shock, SepticDISEASEmay_treatphenylephrine
MEDRTD012772Shock, SepticDISEASEmay_treatphenylephrine hydrochloride
MEDRTD013224Status AsthmaticusDISEASEci_withchlorpheniramine
MEDRTD013224Status AsthmaticusDISEASEci_withchlorpheniramine maleate
MEDRTD013617Tachycardia, SupraventricularDISEASEmay_treatphenylephrine
MEDRTD013617Tachycardia, SupraventricularDISEASEmay_treatphenylephrine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEci_withphenylephrine
MEDRTD017180Tachycardia, VentricularDISEASEci_withphenylephrine hydrochloride
MEDRTD001748Urinary Bladder Neck ObstructionDISEASEci_withchlorpheniramine maleate
MEDRTD001748Urinary Bladder Neck ObstructionDISEASEci_withchlorpheniramine
MEDRTD014581UrticariaDISEASEmay_treatphenyltoloxamine citrate
MEDRTD014581UrticariaDISEASEmay_treatphenyltoloxamine
MEDRTD014581UrticariaDISEASEmay_treatchlorpheniramine maleate
MEDRTD014581UrticariaDISEASEmay_treatchlorpheniramine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaphenylephrine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaphenylephrine hydrochloride
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moaphenyltoloxamine citrate
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moaphenyltoloxamine
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moachlorpheniramine maleate
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moachlorpheniramine
MEDRTN0000175439AnalgesiaPEhas_pephenyltoloxamine citrate
MEDRTN0000175439AnalgesiaPEhas_pephenyltoloxamine
MEDRTN0000008371Conjunctival Arterial VasoconstrictionPEhas_pephenylephrine
MEDRTN0000008371Conjunctival Arterial VasoconstrictionPEhas_pephenylephrine hydrochloride
MEDRTN0000008657Decreased Histamine ActivityPEhas_pechlorpheniramine
MEDRTN0000008657Decreased Histamine ActivityPEhas_pechlorpheniramine maleate
MEDRTN0000008657Decreased Histamine ActivityPEhas_pephenyltoloxamine
MEDRTN0000008657Decreased Histamine ActivityPEhas_pephenyltoloxamine citrate
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_pephenylephrine
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_pephenylephrine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSCD
CODESMMSL_CODEBD6732
CODESMMSL_CODECD6732
CODESRxCUI1308442
NAMESPrescribable Synonymchlorpheniramine maleate 2.5 MG / phenylephrine hydrochloride 5 MG / phenyltoloxamine citrate 7.5 MG in 5 mL Oral Solution
NAMESRXNAV_STRchlorpheniramine maleate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenyltoloxamine citrate 1.5 MG/ML Oral Solution
NAMESRxNorm Namechlorpheniramine maleate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML / phenyltoloxamine citrate 1.5 MG/ML Oral Solution
NAMESRxNorm Synonymchlorpheniramine maleate 2.5 MG / phenylephrine hydrochloride 5 MG / phenyltoloxamine citrate 7.5 MG per 5 ML Oral Solution
SOURCESSourceMultum MediSource Lexicon